07:00 , Aug 1, 2013 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer Hyaluronan synthase 2 (HAS2); hyaluronidase 2 (HYAL2) In vitro and rodent...
07:00 , Jul 14, 2011 |  BC Innovations  |  Distillery Therapeutics

Indication: Pulmonary disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Pulmonary disease Pulmonary fibrosis Hyaluronan synthase 2 (HAS2) In vitro and mouse studies suggest inhibiting HAS2 could...